Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

18.87 +0.75 (+4.14%)
Streaming Delayed Price Updated: 1:24 PM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 188,616
Open 18.28
Bid (Size) 18.85 (300)
Ask (Size) 18.88 (200)
Prev. Close 18.12
Today's Range 18.28 - 18.89
52wk Range 16.64 - 31.26
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag ↗
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in... 
Via MarketBeat
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
Via ACCESS Newswire

Performance

YTD
-28.7%
-28.7%
1 Month
-17.0%
-17.0%
3 Month
-5.5%
-5.5%
6 Month
-31.6%
-31.6%
1 Year
-27.5%
-27.5%

More News

Read More
News headline image
3 Stocks Under $50 with Open Questions
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
Via StockStory
Amphastar (AMPH) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 Results Miss Estimates, Stock Slides After Hours ↗
Via Chartmill
News headline image
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook ↗
Via MarketBeat
News headline image
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops
Via StockStory
Topics Artificial Intelligence
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down
Via StockStory
News headline image
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
Via ACCESS Newswire
News headline image
Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today
Via StockStory
Topics Economy
News headline image
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks Supply Chain
News headline image
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy
News headline image
1 Healthcare Stock to Target This Week and 2 We Avoid
Via StockStory
News headline image
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
Via ACCESS Newswire
News headline image
1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Via StockStory
News headline image
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)
Via StockStory
Topics Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 18.87
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 06/04/26 01:24 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 907.30M
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 907M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS